DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Albrecht S, Schochter F, Melcher C et al.
DETECT III – a multicenter, randomized, phase III trial to assess efficacy of lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells (CTCs).
Oncol Res Treat 2014;
37: 29-29
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.